Tatva Chintan Pharma Chem Limited - Penyata Pendapatan (TTM)

Tatva Chintan Pharma Chem Limited
IN ˙ NSEI
₹996.90 ↓ -40.90 (-3.94%)
2025-09-05
HARGA SAHAM
Penyata Pendapatan (TTM)

Tatva Chintan Pharma Chem Limited Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 3,004 3,557 4,192 4,438 4,336 4,152 3,817 3,976 4,236 4,496 4,562 4,198 3,935 3,846 3,714 3,731 3,827 3,941
Perubahan (%) 18.41 17.87 5.86 -2.28 -4.25 -8.07 4.18 6.53 6.13 1.46 -7.98 -6.25 -2.26 -3.43 0.46 2.57 2.98
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 1,574 1,815 2,029 2,159 2,015 1,813 1,766 1,977 2,327 2,443 2,447 2,143 1,830 1,731 1,874 1,916 2,060 2,003
Perubahan (%) 15.30 11.79 6.44 -6.67 -10.03 -2.59 11.96 17.68 5.00 0.18 -12.44 -14.59 -5.39 8.22 2.24 7.53 -2.76
% daripada Hasil 52.40 51.02 48.39 48.65 46.47 43.66 46.26 49.72 54.92 54.34 53.65 51.05 46.51 45.02 50.44 51.34 53.82 50.82
Keuntungan Operasi Kasar 1,430 1,742 2,164 2,279 2,321 2,339 2,051 1,999 1,910 2,053 2,114 2,055 2,105 2,115 1,841 1,816 1,767 1,938
Perubahan (%) 21.84 24.21 5.31 1.88 0.77 -12.32 -2.53 -4.49 7.50 3.00 -2.81 2.45 0.46 -12.96 -1.36 -2.65 9.66
% daripada Hasil 47.60 48.98 51.61 51.35 53.53 56.34 53.74 50.28 45.08 45.66 46.35 48.95 53.49 54.98 49.56 48.66 46.18 49.18
SG&A 253 279 300 311 320 324 353 377 431 416 483 526 563 552 548 548 545 543
Perubahan (%) 10.67 7.49 3.68 2.61 1.25 9.17 6.62 14.40 -3.50 16.24 8.83 7.05 -1.88 -0.84 -0.01 -0.46 -0.40
% daripada Hasil 8.41 7.86 7.17 7.02 7.37 7.79 9.25 9.47 10.17 9.25 10.60 12.53 14.31 14.36 14.75 14.68 14.25 13.78
R&D
Perubahan (%)
% daripada Hasil
OpEx 2,402 2,797 3,141 3,399 3,332 3,267 3,091 3,320 3,651 3,888 3,906 3,653 3,497 3,514 3,517 3,573 3,760 3,852
Perubahan (%) 16.46 12.30 8.20 -1.98 -1.95 -5.38 7.41 9.99 6.48 0.47 -6.47 -4.28 0.48 0.09 1.59 5.24 2.43
% daripada Hasil 79.96 78.65 74.93 76.59 76.83 78.67 80.97 83.49 86.20 86.48 85.64 87.04 88.87 91.37 94.69 95.76 98.25 97.73
Pendapatan operasi 602 759 1,051 1,039 1,005 886 726 656 585 608 655 544 438 332 197 158 67 90
Perubahan (%) 26.18 38.39 -1.14 -3.28 -11.86 -17.99 -9.61 -10.94 3.92 7.83 -16.97 -19.52 -24.15 -40.67 -19.73 -57.75 34.14
% daripada Hasil 20.04 21.35 25.07 23.41 23.17 21.33 19.03 16.51 13.80 13.52 14.36 12.96 11.13 8.63 5.31 4.24 1.75 2.27
Perbelanjaan Faedah -40 -61 -46 -45 -44 -44 -39 -58 -80 -103 -111 -91 -62 -39 -7 -7 -9 -14
Perubahan (%) 53.88 -25.07 -2.63 -2.75 1.36 -10.50 46.59 38.21 28.37 8.28 -18.06 -32.47 -36.27 -82.22 5.60 21.74 55.02
% daripada Hasil -1.33 -1.72 -1.10 -1.01 -1.00 -1.06 -1.03 -1.46 -1.89 -2.28 -2.44 -2.17 -1.56 -1.02 -0.19 -0.20 -0.23 -0.35
Pendapatan bersih 523 687 976 995 959 825 572 460 455 452 459 377 304 261 176 143 57 72
Perubahan (%) 31.45 42.00 1.98 -3.63 -13.92 -30.66 -19.55 -1.20 -0.64 1.48 -17.80 -19.48 -14.15 -32.41 -18.83 -60.04 25.24
% daripada Hasil 17.40 19.32 23.27 22.42 22.11 19.88 14.99 11.58 10.74 10.05 10.05 8.98 7.71 6.78 4.74 3.83 1.49 1.82

Source: Capital IQ

Other Listings
IN:543321
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista